Switch theme
Sign up to access all valuation multiples
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.
1970
4.5K+
LTM Revenue n/a
LTM EBITDA n/a
$443M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Tempo Scan Pacific has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Tempo Scan Pacific achieved revenue of $820M and an EBITDA of $139M.
Tempo Scan Pacific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Tempo Scan Pacific valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $788M | $820M | XXX | XXX | XXX |
| Gross Profit | $250M | $283M | XXX | XXX | XXX |
| Gross Margin | 32% | 34% | XXX | XXX | XXX |
| EBITDA | $112M | $139M | XXX | XXX | XXX |
| EBITDA Margin | 14% | 17% | XXX | XXX | XXX |
| Net Profit | $60.2M | $70.7M | XXX | XXX | XXX |
| Net Margin | 8% | 9% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Tempo Scan Pacific's stock price is IDR 2460 (or $0).
Tempo Scan Pacific has current market cap of IDR 11.09T (or $667M), and EV of IDR 7.37T (or $443M).
See Tempo Scan Pacific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $443M | $667M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Tempo Scan Pacific has market cap of $667M and EV of $443M.
Tempo Scan Pacific's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Tempo Scan Pacific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Tempo Scan Pacific and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $443M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 3.2x | XXX | XXX | XXX |
| P/E | 7.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 5.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTempo Scan Pacific's NTM/LTM revenue growth is n/a
Tempo Scan Pacific's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $45K for the same period.
Over next 12 months, Tempo Scan Pacific's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Tempo Scan Pacific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Tempo Scan Pacific and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 24% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $45K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 14% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 25% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Tempo Scan Pacific acquired XXX companies to date.
Last acquisition by Tempo Scan Pacific was XXXXXXXX, XXXXX XXXXX XXXXXX . Tempo Scan Pacific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Tempo Scan Pacific founded? | Tempo Scan Pacific was founded in 1970. |
| Where is Tempo Scan Pacific headquartered? | Tempo Scan Pacific is headquartered in Indonesia. |
| How many employees does Tempo Scan Pacific have? | As of today, Tempo Scan Pacific has 4.5K+ employees. |
| Is Tempo Scan Pacific publicy listed? | Yes, Tempo Scan Pacific is a public company listed on IDX. |
| What is the stock symbol of Tempo Scan Pacific? | Tempo Scan Pacific trades under TSPC ticker. |
| When did Tempo Scan Pacific go public? | Tempo Scan Pacific went public in 1994. |
| Who are competitors of Tempo Scan Pacific? | Similar companies to Tempo Scan Pacific include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Tempo Scan Pacific? | Tempo Scan Pacific's current market cap is $667M |
| What is the current revenue growth of Tempo Scan Pacific? | Tempo Scan Pacific revenue growth between 2023 and 2024 was 4%. |
| Is Tempo Scan Pacific profitable? | Yes, Tempo Scan Pacific is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
